Abdul Mannan: Venous Thromboembolism Prophylaxis Is Often Overlooked in Medical Inpatients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Venous thromboembolism remains a leading cause of preventable hospital deaths, yet prophylaxis is often overlooked in medical inpatients. Evidence shows that systematic risk assessment using tools like the Padua Score, combined with bleeding-risk stratification (IMPROVE), saves lives. Pharmacological prophylaxis with LMWH reduces VTE by up to 50% in at-risk patients, whilst mechanical methods offer alternatives when bleeding risk is high. As clinicians, we must embed VTE assessment into daily practice—document decisions, reassess regularly, and champion mechanical prophylaxis when pharmacological options are contraindicated. Let’s ensure every patient receives the right prophylaxis at the right time. Prevention is always better than treatment.”
Learn more here.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?